详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Xu Huji[1] * ; Li Zhijun[2] ; Jian, Wu[3] ; Qian, Xing[4] ; Shi, Guixiu[5] ; Juan, Li[6] ; Xu, Liu[7] ; Wu, Lijun[8] ; Li Xiaomei[9] ; Tan Wenfeng[10] ; He, Dongyi[11] ; Bi Liqi[12] ; Li Hongbin[13] ; Xiao Zhengyu[14] ; Shuai Zongwen[15] ; Li Xiaoxia[16] ; Wang Yongfu[17] ; Li, Luo[18] ; Yi, Zheng[19] ; Xiao Weiguo[20] ; Hui, Zhou[21] ; Lu Yushan[21] ; Zheng Shirui[21] ; Xiong, Wang[21] ;

单位： [1]Shanghai Changzheng Hospital, Shanghai, China, [2]The First Afiliated Hospital of Bengbu Medical College, Bengbu, China, [3]The First ffiliated Hospital of Soochow University, Suzhou, China, [4]Qingdao municipal hospital, Qingdao, China, [5]The First Afiliated Hospital of Xiamen University, Xiamen, China, [6]Nanfang Hospital, Southern Medical University, Guangzhou, China, [7]Peking University People's Hospitalv, Bejig, China, [8]people's Hospital ofXinjiang Uygur Autonomous Region, Wulumuqi, China, [9]Anhui Provincial Hospital, Hefei, China, [10]jiangsu Province Hospital, Nanjing, China, [11]Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China, [12]China-Japan Friendship Hospital, Changchun, China, [13]The Affliated Hospital of Inner Mongolia Medical University, Huhehaote, China, [14]The First Affiliated Hospital of Shantou University Medical College, Shantou, China, [15]The First Affiliated Hospital of Anhui Medical University, Hefei, China, [16]Xuanwu Hospital Capital Medical University, Bejing, China, [17]The First ffiliated Hospital of Baotou Medical College of Inner Mongolia University of Science & Technology, Baotou, China, [18]The First ffilited Hospital of Xinjiang Medical University, Wulumuqi, China, [19]Bejjing Chao-Yang Hospital, Capital Medical University, Bejing, China, [20]The First Hospital of China Medical University, Shenyang, China, [21]Innovent Biologics (Suzhou) Co. Ltd, Shanghai, China

出处：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2017]版：

大类 | 1 区

医学

小类 | 1 区风湿病学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区风湿病学

JCR分区：

出版当年[2016]版：

Q1 RHEUMATOLOGY

最新[2023]版：

Q1 RHEUMATOLOGY

第一作者：

第一作者单位： [1]Shanghai Changzheng Hospital, Shanghai, China,

推荐引用方式(GB/T 7714)：

APA：

MLA：

Similar Efficacy and Safety of Biosimilar Candidate IBI303 and Reference Products of Adalimumab in Patients with Ankylosing Spondylitis: Results from a Randomized, Double-Blind, Phase III Study

文献详情